Background: Alcohol consumption, current injecting drug use, and pre-existing mental illness have been identified as 3 of the main reasons for excluding patients from treatment for hepatitis C. Objectives: We reviewed the literature to obtain an evidence base for these common exclusion criteria. Materials and Methods: We reviewed original research and meta-analyses investigating the effects of alcohol consumption, current injecting drug use, and pre-existing mental illness. Results: We identified 66 study reports relevant to the review, but found only limited evidence to support withholding of treatment on the basis of the 3 previously mentioned exclusion criteria. Conclusions: Currently, there is a lack of evidence for many of the barriers...
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepati...
Hepatitis C virus (HCV) infection affects millions of Americans at a high public health cost. Despit...
Background: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has ...
Although injection drug users represent the majority of incident and prevalent cases of hepatitis C,...
Background: Hepatitis C virus (HCV)-related morbidity and mortality are rising. Despite recent thera...
In light of current initiatives to increase hepatitis C treatment uptake amongst current and former ...
Introduction and Aims: People who inject drugs (PWID) constitute the largest reservoir of hepatitis ...
Background: Illicit drug users account for the majority of cases of HCV in the developed world, but ...
Background. Although guidelines recommend that people who inject drugs (PWID) should not be excluded...
Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, ...
Introduction and Aims: People who inject drugs (PWID) constitute the largest reservoir of hepatitis ...
Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, ...
Background: Hepatitis C virus (HCV) management is a challenge in patients with substance use disorde...
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepati...
Introduction\ud \ud Access to hepatitis C (hereafter HCV) antiviral therapy has commonly excluded po...
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepati...
Hepatitis C virus (HCV) infection affects millions of Americans at a high public health cost. Despit...
Background: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has ...
Although injection drug users represent the majority of incident and prevalent cases of hepatitis C,...
Background: Hepatitis C virus (HCV)-related morbidity and mortality are rising. Despite recent thera...
In light of current initiatives to increase hepatitis C treatment uptake amongst current and former ...
Introduction and Aims: People who inject drugs (PWID) constitute the largest reservoir of hepatitis ...
Background: Illicit drug users account for the majority of cases of HCV in the developed world, but ...
Background. Although guidelines recommend that people who inject drugs (PWID) should not be excluded...
Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, ...
Introduction and Aims: People who inject drugs (PWID) constitute the largest reservoir of hepatitis ...
Hepatitis C (HCV) infection is common among injecting drug users (IDUs), yet accessing of HCV care, ...
Background: Hepatitis C virus (HCV) management is a challenge in patients with substance use disorde...
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepati...
Introduction\ud \ud Access to hepatitis C (hereafter HCV) antiviral therapy has commonly excluded po...
Although guidelines recommend that people who inject drugs (PWID) should not be excluded from hepati...
Hepatitis C virus (HCV) infection affects millions of Americans at a high public health cost. Despit...
Background: A barrier to hepatitis C virus (HCV) treatment among people who inject drugs (PWID) has ...